epigallocatechin gallate has been researched along with Diabetic Angiopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Tang, L; Yang, J; Zeng, C | 1 |
| Lombo, C; Morgado, C; Neves, D; Tavares, I | 1 |
2 other study(ies) available for epigallocatechin gallate and Diabetic Angiopathies
| Article | Year |
|---|---|
Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes.
Topics: Catechin; Diabetic Angiopathies; Humans; Protective Agents | 2017 |
Effects of prolonged ingestion of epigallocatechin gallate on diabetes type 1-induced vascular modifications in the erectile tissue of rats.
Topics: Animals; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Male; Muscle, Smooth; Penis; Rats; Rats, Wistar; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2016 |